Author | Bridget F. Koontz, MD | OncLive

Author | Bridget F. Koontz, MD

Articles

Dr. Koontz on Next Steps for Study of LHRH in Prostate Cancer

February 20, 2018

Video

Bridget F. Koontz, MD, radiation oncologist, Duke Cancer Institute, discusses the next steps for the phase II trial of 6 months of androgen deprivation therapy/abiraterone acetate (Zytiga) plus prednisone and definitive radiotherapy for men with intermediate- to high-risk localized prostate cancer.

Dr. Koontz Discusses LHRH in High-Risk Prostate Cancer

February 14, 2018

Video

Bridget F. Koontz, MD, radiation oncologist, Duke Cancer Institute, discusses a phase II trial of 6 months of androgen deprivation therapy/abiraterone acetate (Zytiga) plus prednisone and definitive radiotherapy for men with intermediate- to high-risk localized prostate cancer.

x